• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Nicholas Robert Explains the Need to Standardize Use of RWE for Measuring Clinical End Points

Video

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the need for standardizing the use of real-world evidence for measuring endpoints in clinical practice.

Transcript

How do challenges associated with variation in the use of real-world evidence for measuring endpoints in clinical practice highlight the need for standardization, and are there any potential ways that have been identified to do this?

I think harmonization of results from different groups is absolutely necessary. Friends of Cancer Research actually has provided some leadership. They recently did a study looking at the management of lung cancer using multiple groups. They are now doing a second iteration of that, and we’re happy to say that we’re going to be participating and this will be an opportunity to use common terms and see how much overlap of agreement there is from different data sources.

Related Videos
Lawrence F Eichenfield, MD, FAAD.
Douglas Flora, MD, FACCC
Rebecca Vasquez, MD, FAAD
Jorge García, PharmD, MS, MBA, MHA, FACHE, FACCC
Annie Antar, MD, PhD, Johns Hopkins Medicine
SECO 2025
Brianna Rhue, OD, FAAO
Julie Rodman, OD, MS, FAAO
Nate Lighthizer, OD, FAAO
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.